Hickson RP et al (2019): Implications of Removing Rosiglitazones Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes
Generally, when we consume food, GLP-1 is released in the gut, which triggers the brain to reduce hunger, slow down digestion and manage blood glucose levels
Clinical implications of gastric complications on levodopa treatment in Parkinsons disease
( PMID: 24697291 ) Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD, Exenatide-113 Clinical Study Group (2004) Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
Researchers buy BPC-157 because it is one of the most studied peptides in tissue-repair science
A similar dose-dependent effect on nausea and abdominal discomfort has been found following exogenous administration of PYY 336 in humans (49)